With billions of dollars at stake, Merck and Palantir partner to discover drugs faster

shutterstock drugs Merck, the German multinational chemical and pharmaceutical company, is teaming up with Silicon Valley’s highest-profile data and analysis software company, Palantir, to more quickly develop new drugs and, hopefully, improve patient outcomes.
The idea at the start is for the companies to partner on three of Merck’s business sectors: healthcare, life sciences, and performance… Read More


This entry has 0 replies

Comments are closed.